Page last updated: 2024-10-21

1,3-dipropyl-8-cyclopentylxanthine and Ventricular Fibrillation

1,3-dipropyl-8-cyclopentylxanthine has been researched along with Ventricular Fibrillation in 2 studies

DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.

Ventricular Fibrillation: A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chi, L1
Friedrichs, GS1
Oh, JY1
Green, AL1
Lucchesi, BR1
Schreieck, J1
Richardt, G1

Other Studies

2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Ventricular Fibrillation

ArticleYear
Effect of Ado A1- and A2-receptor activation on ventricular fibrillation during hypoxia-reoxygenation.
    The American journal of physiology, 1994, Volume: 267, Issue:4 Pt 2

    Topics: Action Potentials; Adenosine; Animals; Electrolytes; Heart; Homeostasis; In Vitro Techniques; Kineti

1994
Endogenous adenosine reduces the occurrence of ischemia-induced ventricular fibrillation in rat heart.
    Journal of molecular and cellular cardiology, 1999, Volume: 31, Issue:1

    Topics: Adenine; Adenosine; Aminoimidazole Carboxamide; Animals; Caffeine; Creatine Kinase; Electrocardiogra

1999